The Cooper Neurological Institute Offers the Highest Level of Epilepsy Care

LOGOAECLogoCMYKThe Cooper Neurological Institute (CNI) Epilepsy Program has been accredited as a Level 4 epilepsy center by the National Association of Epilepsy Centers (NAEC)—a designation reserved for hospitals and medical centers offering the most comprehensive and specialized epilepsy care.

As the highest recognition given by the NAEC, the Level 4 recognizes Cooper for having the professional expertise and facilities capable of providing more complex and progressive forms of medical and surgical evaluation and treatment for this disorder as well as education, psychosocial counseling, social services and more.

“This national recognition is a true testament to the high-level of specialized patient-centered care Cooper provides for patients with epilepsy, including individuals who may be viewed as complicated or untreatable,” Melissa Carran, MD, Chair and Chief, Department of Neurology. “Our goal is to help reduce, control or even eliminate the seizures associated with the disorder in order to restore a person to a normal, productive life.”

Epilepsy, a disorder that causes abnormal electrical activity in the brain (seizures), is one of the country’s most common disabling neurological conditions, affecting more than 2.5 million Americans. Those affected by epilepsy are generally the very young and the elderly. The disorder has many causes including brain injury, infection, stroke, tumor or hereditary factors.  In some cases, the exact cause cannot be identified. Treatment for the disorder often involves surgery.

In 1989, the NAEC created guidelines for specialized epilepsy centers that focused on early and accurate diagnosis and appropriate intervention for patients with epilepsy. This document was the first of its kind, and became a nationally recognized and accepted set of guidelines for practitioners and administrators of specialized epilepsy care. The NAEC Board has spent the past several years developing and implementing a process to more formally accredit specialized epilepsy centers.

CNI is dedicated to the diagnosis and treatment of a wide-range of neurological and neurosurgical conditions including spinal trauma, stroke and hydrocephalus, as well as providing comprehensive neuro-oncology and neuromuscular care. As part of CNI, the Epilepsy Treatment Program provides comprehensive evaluation and treatment of individuals who have poorly controlled epilepsy.

Wendy A. Marano
Public Relations Manager
marano-wendy@cooperhealth.edu
Office: 856.382.6463
Cell: 856.904.1688

Posted in Newsmakers, Press Releases0 Comments

Pinwheel Garden Planted at Cooper University Hospital To Recognize Child Abuse Awareness Month

Pinwheel planting 2016 002Employees and staff of Cooper University Health Care “planted” a pinwheel garden on the front lawn of Cooper University Hospital in honor of Child Abuse and Neglect Prevention and Awareness Month. The 59 blue pinwheels placed represent the approximately 59,000 households in Camden County with children under the age of 18. In addition, the exterior of Cooper University Hospital is aglow in blue lights throughout the month of April to bring further awareness.

“Child abuse and neglect ruin children’s lives,” said Kathryn M. McCans, MD, FAAP, attending physician in Cooper’s department of Pediatric Emergency Medicine and expert in child abuse and neglect.  “The pinwheel garden brings much-needed attention to the problem and is a stunning reminder how important it is for everyone to play a role in proving our children with a safe and nurturing life.”

According to the most recent statistics, more than 700,000 children annually are victims of maltreatment. More than 1,500 died as a result of abuse or neglect. Cooper is partnering with Prevent Child Abuse New Jersey’s “Pinwheels for Prevention” campaign to recognize and educate our community on the problem.

“These children deserve better and it’s our job to raise awareness and get these families help before another innocent child is hurt. Speak up and tell someone if you suspect abuse, you could be saving a child’s life,” implored Dr. McCans.

Prevent Child Abuse America’s Pinwheels for Prevention campaign is an effort created to change the way our nation thinks about prevention and how we can deliver on our commitment to America’s children. The blue pinwheels are the new symbol for child abuse and are an uplifting reminder of childhood and the bright futures all children deserve. To learn more please visit pinwheelsforprevention.org.

Contact: Wendy A. Marano
Cooper University Health Care
marano-wendy@cooperhealth.edu
Office: 856.382.6469
Cell: 856.904.1688

Posted in Newsmakers, Press Releases0 Comments

March is Colorectal Cancer Awareness Month

Cooper University Health Care Joins Forces With More Than 500 Local and National Organizations to Increase Colorectal Cancer Screenings Rates Across the Country

“80% by 2018” is a shared goal to have 80 percent of adults aged 50 and older regularly screened for colorectal cancer by 2018.
80% by 2018
Colorectal cancer screening has been proven to save lives. MD Anderson Cancer Center at Cooper is making the pledge to help increase colorectal cancer screening rates by supporting the 80% by 2018 initiative, led by the American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), and the National Colorectal Cancer Roundtable (an organization co-founded by ACS and CDC), announced Generosa Grana, MD, director of MD Anderson Cooper.

Colorectal cancer is the nation’s second-leading cause of cancer-related deaths; however, it is one of only a few cancers that can be prevented. Through proper colorectal cancer screening, doctors can find and remove hidden growths (called “polyps”) in the colon, before they become cancerous. Removing polyps can prevent cancer altogether.

“80%by 2018” is a National Colorectal Cancer Roundtable (NCCRT) initiative in which more than 500 organizations have committed to substantially reducing colorectal cancer as a major public health problem and are working toward the shared goal of 80 percent of adults aged 50 and older being regularly screened for colorectal cancer by 2018. Leading public health organizations such as ACS, CDC, and the NCCRT are rallying organizations to embrace this shared goal.

“Colorectal cancer is a major public health problem, and adults age 50 and older should be regularly screened for it, but we have found that many people aren’t getting tested because they don’t believe they are at risk, don’t understand that there are testing options, or don’t think they can afford it,” said Steven R. Peikin, MD, FACG, AGAF, Head, Division of Gastroenterology and Liver Diseases at Cooper.

“The truth is that the vast majority of cases of colorectal cancer occur in people age 50 and older. Colorectal cancer in its early stages usually has no symptoms, so everyone 50 and older should get tested. There are several screening options – even take-home options – available. Plus, many public and private insurance plans cover colorectal cancer screening and there may be local resources available to help those that are uninsured.”

While colorectal cancer incidence rates have dropped 30 percent in the U.S. over the last 10 years among adults 50 and older, it is still the second leading cause of cancer death in the U.S, despite being highly preventable, detectable, and treatable. In fact, in 2015 in the U.S., 132,700 cases of colorectal cancer were diagnosed.

Part of the 80% by 2018 goal is to leverage the energy of multiple and diverse partners to empower communities, patients, and providers to increase screening rates. The 80% by 2018 initiative consists of health care providers, health systems, communities, businesses, community health centers, government, non-profit organizations, and patient advocacy groups who are committed to getting more people screened for colorectal cancer to prevent more cancers and save lives.

“At Cooper, we are thrilled to join the cause to improve colorectal cancer screening rates,” said Dr. Peikin. “We are asking all members of our community to come together and help us by getting screened and talking to your friends and family who are over 50 years of age about getting screened. Together, we can help to eliminate colorectal cancer as a major public health problem.”

Contact: Wendy A. Marano
Cooper University Health Care
marano-wendy@cooperhealth.edu
Office: 856.382.6469
Cell: 856.904.1688

Posted in Newsmakers, Press Releases0 Comments

Researchers at Cooper University Health Care find link between better patient experience and favorable medical outcomes in U.S. hospitals

For many years, the medical community has debated whether a positive patient experience (often termed “patient satisfaction”) has an impact on clinical outcomes in the hospital. While a correlation was thought to exist, a new study published March 17 in the Journal of Patient Experience by researchers at Cooper University Health Care shows that there is an association between a positive patient experience and favorable clinical outcomes in U.S. hospitals.

While providing a positive patient experience has always been a focus for hospitals, the issue has become more important in recent years as patient satisfaction data gathered by hospitals is used by the Centers for Medicare and Medicaid Services (CMS) in determining payment to health care organizations. Similarly, some private insurers are also starting to tie a hospital’s patient satisfaction performance to reimbursement rates. To further promote public transparency of hospital performance, in 2015 CMS released new summary star ratings of U.S. hospitals based on their patient experience data.

“While all of these initiatives have been put in place, the relationship between patient experience and clinical outcomes has not been entirely clear, and this has been the subject of controversy in the medical community,” said lead author Stephen W. Trzeciak, MD, MPH, Head of the Division of Critical Care Medicine at Cooper and a Professor of Medicine at Cooper Medical School of Rowan University (CMSRU). “Our goal in this study was to test the association between CMS patient experience star ratings and clinical outcomes by analyzing risk-adjusted data for more than 3,000 U.S. hospitals from the CMS Hospital Compare database.”

The patient experience star-rating system reflects hospitals’ overall performance on the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey which covers subjects such as listening and communication by care providers, treatment with respect and courtesy, timeliness of assistance, and quality of discharge instructions.

This information was analyzed along with Medicare claims data from Hospital Compare which looks at clinical outcomes such as complications following treatments or surgery, a variety of hospital acquired infections, joint replacement complications, and readmission rates following certain diagnoses such as stroke, heart attacks, congestive heart failure, and pneumonia, among others.

“When we analyzed the two sets of measures,” Dr. Trzeciak said, “we found a significant association between better patient experience and multiple clinical outcomes, with the most consistent association found between higher star ratings and lower readmission to the hospital.

“Multiple potential theories exist that could explain this association and more study is needed. One theory is that health care providers who are diligent about providing an excellent patient experience may be similarly diligent about excellence in all aspects of patient care. Another theory is that an excellent patient experience may inspire patient confidence and adherence to a treatment plan both in the hospital and following discharge.”

Co-authors of the study included John P. Gaughan, a biostatistician at Cooper; Joshua Bosire, Assistant Vice President of Customer Services and Access at Cooper; and Anthony J. Mazzarelli, MD, JD, MBE, Senior Executive Vice President and Chief Physician Executive and Assistant Professor of Emergency Medicine at CMSRU.

The complete study can be found at http://jpx.sagepub.com/content/3/1/2374373516636681.full.pdf+html

Wendy A. Marano
Cooper University Health Care
marano-wendy@cooperhealth.edu
Cell: 856.904.1688

Posted in Announcements, Press Releases0 Comments

Distinguished Vascular Surgeon and International Researcher Opens Moorestown Practice

Moorestown Township will be home to one of the top vascular and endovascular surgeons in the nation as rated by U.S. News & World Report. Jeffrey P. Carpenter, MD, Chairman and Chief of the Department of Surgery and Vice President of Perioperative Services at Cooper University Health Care, has opened a new office located at 110 Marter Avenue, Building 500, Suite 503 Moorestown, NJ.

A Moorestown resident, Dr. Carpenter is a distinguished vascular surgeon and international researcher.

Dr. Carpenter joined Cooper in 2008 as Chief of the Department of Surgery. He has dedicated his entire career to innovating the field of vascular and endovascular surgery and continues to do so by his commitment to research and education. His special interests include abdominal and thoracic aortic aneurysms, carotid arterial disease, peripheral vascular disease and endovascular surgery. Dr. Carpenter serves or has served on the editorial boards of the Journal of Vascular Surgery, Vascular and Endovascular Surgery, the Journal of Vascular and Endovascular Therapy, Vascular and several other journals. Dr. Carpenter is well published in his field with more than 250 papers.

In January 2014, vascular surgeons at Cooper were the first in North America to treat  abdominal aortic aneurysms (AAA) with a new generation sealing system when they implanted the first, investigational Nellix® EVAS graft from Endologix as part of a global, multi-center clinical trial.

Dr.  Carpenter serves as the study’s Global Principal Investigator. “Nellix represents the first meaningful advancement in abdominal aortic aneurysm repair since endovascular grafts were introduced in the late 1990s,” said Dr. Carpenter. “This is ground-breaking treatment that will help many patients and dramatically change how we treat abdominal aortic aneurysms. I look forward to growing my new Moorestown office practice and bringing these innovative treatments to my patients.”

Recently, the 30-day results of the Nellix IDE pivotal study were published in the Journal of Vascular Surgery.  The results showed that in selected patients, the perioperative outcomes were encouraging, achieving high procedural success with very low endoleak rate, morbidity and mortality.

U.S. News & World Report’s “Top Doctors” rankings place Dr. Carpenter in the top 1 percent of vascular and endovascular surgeons nationwide for 2011, 2012, 2013 and 2014. In 2015, Dr. Carpenter received a Lifetime Achievement Award from the Delaware Valley Vascular Society.

For more information or to schedule an appointment with Dr. Carpenter, call 856.342.2151.

Contact:
Wendy A. Marano
marano-wendy@cooperhealth.edu
Office: 856.382.6469
Cell: 856.904.1688

Posted in Newsmakers, Press Releases0 Comments